Live Audio Room

No related audio room.

Related Events

No related events.

Latest Feed

May 16, 2024

14 mins ago

# of Events: 0

BIGG Digital Assets Subsidiary TerraZero Technologies Inc. and Napster Unveil Second Phase of Artist Metaverse Experiences: Ric Wilson to Host Exclusive Q&A and Artist Chat in Napster Virtual Hangout

BIGG Digital Assets Subsidiary TerraZero Technologies Inc. and Napster Unveil Second Phase of Artist Metaverse Experiences: Ric Wilson Exclusive Q&A

BBKCF

181686

News

May 16, 2024

14 mins ago

# of Events: 0

Security National Financial Corporation Introduces its new Loyalty Sales Division

SALT LAKE CITY, May 16, 2024 (GLOBE NEWSWIRE) — Security National Financial Corporation (SNFC) (NASDAQ symbol “SNFCA”) announced a new sales division within Security National Life Insurance Company (SNL).

SNFCA

181685

News

May 16, 2024

25 mins ago

# of Events: 0

Sunrun Releases 2023 Impact Report

Seventh annual Impact Report highlights Sunrun’s continued progress toward its impact goals, social and environment stewardship, and operating responsibly Seventh annual Impact Report highlights Sunrun’s continued progress toward its impact goals, social and environment stewardship, and operating responsibly

RUN

181687

News

Related on Reddit

Related on X

Related on YouTube

Back

April 29, 2024

2 weeks ago

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

MALVERN, Pa., April 29, 2024 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, such as Alzheimer’s (AD) and Parkinson’s disease (PD), today announced the data from its Phase II/III Alzheimer study of buntanetap in mild to moderate AD patients. Based on these data, the Company plans to conduct a pivotal Phase III trial in biomarker-positive early AD patients.